There is reasonable evidence from prospective epidemiological studies which suggests that cannabis use can precipitate schizophrenia in persons who are vulnerable because of a personal or family history of schizophrenia. There is also evidence that a genetic vulnerability to psychosis increases the risk that cannabis users will develop psychosis (McGuire et al., 1995; Arseneault et al., 2002; Verdoux et al., 2002). A casual relationship also has biological plausibility in that the cannabinoid and dopaminergic neurotransmitter systems interact in animals. D'Souza and colleagues (1999) have shown in a provocation study that THC produces a dose-dependent increase in psychotic symptoms under double-blind placebo conditions; and Caspi and colleagues (2005) have shown an interaction between specific alleles of the COMT allele and psychotogenic effects of cannabis. If these results can be replicated and extended, they will increase the likelihood that cannabis can be a contributory cause of psychosis in vulnerable individuals.
The phytocannabinoid cannabidiol (CBD), is a non-intoxicating molecule that results from the heating, or decarboxylation, of cannabidiolic acid, or CBDA. As popular as CBD has become in both the cannabis community and mainstream consumerism, its natural precursor, CBDA, is one of 114 unique cannabinoids found in cannabis. In most cultivars, or cultivated varieties of cannabis, CBD ranks low on the expression chart; there often isn’t much. However, following a explosive discovery in 2009 — it was noted that a handful of strains are rich in CBD over THC. Droves of CBD-rich cultivars began cropping up all across the US, resulting in a marked uptick in CBD availability across the states.
Cannabis plants can be male, female, or hermaphrodite. The dried marijuana flowers that humans consume, however, come from the female plant. That’s because female plants produce large resin-secreting flowers that are rich in cannabinoids and free of seeds. Hence, female plants are the ones growers prefer, though of course, male marijuana plants are a requirement for pollination.
Whether the drug and non-drug, cultivated and wild types of Cannabis constitute a single, highly variable species, or the genus is polytypic with more than one species, has been a subject of debate for well over two centuries. This is a contentious issue because there is no universally accepted definition of a species. One widely applied criterion for species recognition is that species are "groups of actually or potentially interbreeding natural populations which are reproductively isolated from other such groups." Populations that are physiologically capable of interbreeding, but morphologically or genetically divergent and isolated by geography or ecology, are sometimes considered to be separate species. Physiological barriers to reproduction are not known to occur within Cannabis, and plants from widely divergent sources are interfertile. However, physical barriers to gene exchange (such as the Himalayan mountain range) might have enabled Cannabis gene pools to diverge before the onset of human intervention, resulting in speciation. It remains controversial whether sufficient morphological and genetic divergence occurs within the genus as a result of geographical or ecological isolation to justify recognition of more than one species.
Carbon dioxide is passed through the plant material at a very specific temperature and pressure. Carbon dioxide, which is normally a gas at (or above) room temperature, can be pressurized until it becomes so dense that it takes on some of the properties of a liquid while still maintaining the fluid dynamics of a gas. In this state, CO2 is known as a supercritical fluid.
“The Assembly supports the establishment of a centralized regulatory approach for the regulation and management of medical, adult-use and hemp-based cannabis and cannabis products through the creation of a regulatory body comprised of legislative and executive appointments, as well as ex-officio agency representation from agencies involved in implementation.”
Until recent times, the cultivation of hemp primarily as an oilseed was largely unknown, except in Russia. Today, it is difficult to reconstruct the type of plant that was grown there as an oilseed, because such cultivation has essentially been abandoned. Oilseed hemp cultivars in the modern sense were not available until very recently, but some land races certainly were grown specifically for seeds in Russia. Dewey (1914) gave the following information: “The short oil-seed hemp with slender stems, about 30 inches high, bearing compact clusters of seeds and maturing in 60 to 90 days, is of little value for fiber production, but the experimental plants, grown from seed imported from Russia, indicate that it may be valuable as an oil-seed crop to be harvested and threshed in the same manner as oil-seed flax.” Most hemp oilseed in Europe is currently obtained from so-called “dual usage” plants (employed for harvest of both stem fiber and seeds, from the same plants). Of the European dual-usage cultivars, ‘Uniko B’ and ‘Fasamo’ are particularly suited to being grown as oilseeds. Very recently, cultivars have been bred specifically for oilseed production. These include ‘Finola,’ formerly known as ‘Fin-314’ (Fig. 6) and ‘Anka’ (Fig. 7), which are relatively short, little-branched, mature early in north-temperate regions, and are ideal for high-density planting and harvest with conventional equipment. Dewey (1914) noted that a Turkish narcotic type of land race called “Smyrna” was commonly used in the early 20th century in the US to produce birdseed, because (like most narcotic types of Cannabis) it is densely branched, producing many flowers, hence seeds. While oilseed land races in northern Russia would have been short, early-maturing plants in view of the short growing season, in more southern areas oilseed landraces likely had moderate height, and were spaced more widely to allow abundant branching and seed production to develop. Until Canada replaced China in 1998 as a source of imported seeds for the US, most seeds used for various purposes in the US were sterilized and imported from China. Indeed, China remains the largest producer of hempseed. We have grown Chinese hemp land races, and these were short, branched, adapted to a very long growing season (i.e. they come into flower very slowly in response to photoperiodic induction of short days in the fall), and altogether they were rather reminiscent of Dewey’s description of Smyrna. Although similar in appearance to narcotic strains of C. sativa, the Chinese land races we grew were in fact low in intoxicating constituents, and it may well be that what Dewey thought was a narcotic strain was not. Although some forms of C. sativa have quite large seeds, until recently oilseed forms appear to have been mainly selected for a heavy yield of seeds, usually recognizable by abundant branching. Such forms are typically grown at lower densities than hemp grown only for fiber, as this promotes branching, although it should be understood that the genetic propensity for branching has been selected. Percentage or quality of oil in the seeds does not appear to have been important in the past, although selection for these traits is now being conducted. Most significantly, modern selection is occurring with regard to mechanized harvesting, particularly the ability to grow in high density as single-headed stalks with very short branches bearing considerable seed.
A 2012 review found that the THC content in marijuana had increased worldwide from 1970 to 2009. It is unclear, however, whether the increase in THC content has caused people to consume more THC or if users adjust based on the potency of the cannabis. It is likely that the higher THC content allows people to ingest less tar. At the same time, CBD levels in seized samples have lowered, in part because of the desire to produce higher THC levels and because more illegal growers cultivate indoors using artificial lights. This helps avoid detection but reduces the CBD production of the plant.
Cohen has found that chronic conditions including autoimmune diseases and pain syndromes can be helped with a 6-mg under-the-tongue tincture (the fastest delivery system) or a 25-mg capsule taken twice a day. Dosages for topical products like lotions are especially hard to determine—there’s no clarity on how much CBD gets into the system through the skin.
I can’t disagree more with attacking “Big Pharma” or Trump with regards to fixing this problem! Screw the political affiliations for now, let’s change the whole Schedule 1 nightmare. We’re steeped in technology and we have insanely archaic drug laws. Worse, our gov then pressures the countries we give money to (which is all of them) to follow suit by adopting our effed up way. Schedule 1 needs to be dismantled. The research can’t be done on anything listed with very few exceptions. There’s other Sched.1 drugs that need to be available for research by legitimate people, there’s lots of exciting research in psychedelics that’s stalled by archaic laws. That part might just require big pharma to help.
Returning to our CBD article, Dr. Jean Talleyrand, founder and Chief Medical Officer of MediCann in Oakland, California, and co-founder and Chief Medical Officer of The Clinical Endocannabinoid System Consortium in San Diego, California, emphasizes that any “product should be evaluated for its packaging, shelf life, and variance,” as well as third-party testing, which will show strength and purity.
Last year, the National Academies of Sciences, Engineering and Medicine released a nearly 500-page report on the health effects of cannabis and cannabinoids. A committee of 16 experts from a variety of scientific and medical fields analyzed the available evidence — more than 10,000 scientific abstracts in all. Because so few studies examine the effects of CBD on its own, the panel did not issue any findings about CBD specifically, but it did reach some conclusions about cannabis and cannabinoids more generally. The researchers determined that there is “conclusive or substantial evidence” supporting the use of cannabis or cannabinoids for chronic pain in adults, multiple sclerosis-related spasticity (a kind of stiffness and muscle spasms), and chemotherapy-induced nausea and vomiting. The committee also found “moderate” evidence that cannabis or cannabinoids can reduce sleep disturbances in people with obstructive sleep apnea, fibromyalgia, chronic pain and multiple sclerosis, as well as “limited” evidence that these substances can improve symptoms of Tourette’s syndrome, increase appetite and stem weight loss in people with HIV/AIDs, and improve symptoms of PTSD and anxiety.
The results people experience when they start using the CBD oil is what is driving the massive growth. Hemp is an amazing plant and full of beneficial properties. The testimonials I hear every day are amazing. Once you enroll, I can add you to the Hempworx Facebook Group where we all share our stories. If you would like to read some of the results people are experiencing CLICK HERE.
Canada is specialized on oilseed production and processing, so that hemp oil and grain are much more suitable than fiber. Because of the extensive development of oilseeds in Canada, there is extensive capacity to produce high-quality cold-pressed hemp oil. Canada in the last 5 years has made great advances in the growing, harvesting, and processing of hempseed, and indeed has moved ahead of the EU in the development of raw materials and products for the natural foods, nutraceuticals, and cosmetics industries. In the EU, a yield of 1 t/ha is considered good. In Canada, extraordinary yields of 1.5 t/ha have been realized, at least locally, although in the initial years of hempseed development in Canada yields were often less than 500 kg/ha. In 1999, the year of largest Canadian hemp acreage, yields averaged 900 kg/ha. (Ideally, hemp seed yield should be based on air dry weight—with about 12% moisture. Hemp yields are sometime uncertain, and could be exaggerated by as much as 50% when moist weights are reported.)
The dosage on the back label said to give him 1/2 to a full dropper twice a day due to his weight. I gave him 1/2 a dropper with his food. A few hours later I noticed he was wobbling when he walked and tripped up the stairs and collapsed. I took him to my vet and he said there must be THC in the oil. I thought, how can a company sell this product knowing full well that THC is extremely TOXIC for animals! The rep I bought the vials from said I gave him too much and to follow the dosage chart she gave me. Why would I give him anymore of this poison to my dog? Also, why did the product sold to me not have the proper dosage label? Also, I found that this product is Full Spectrum which means there is THC in the product.
FDA AND LEGAL DISCLOSURE: These statements have not been evaluated by the FDA and are not intended to diagnose, treat, cure or prevent any disease. Most work-place drug screens and tests target delta9-tetrahydrocannabinol (THC) and do not detect the presence of Cannabidiol (CBD) or other legal natural hemp based constituents. Even though our products contain less than .3% THC by dry weight (Federal Legal Limit), studies have shown that ingesting Full Spectrum CBD can cause confirmed positive results when screening urine and blood specimens. Accordingly, if you are subject to any form of employment drug testing or screening, we recommend (as does the United States Armed Services) that you DO NOT take our products. Before taking our products, consult with your healthcare practitioner, drug screening testing company or employer. This website requires you to also be at least 18 years or older to purchase our products. Go Here For More CBD Info
Hemp is possibly one of the earliest plants to be cultivated. An archeological site in the Oki Islands near Japan contained cannabis achenes from about 8000 BC, probably signifying use of the plant. Hemp use archaeologically dates back to the Neolithic Age in China, with hemp fiber imprints found on Yangshao culture pottery dating from the 5th millennium BC. The Chinese later used hemp to make clothes, shoes, ropes, and an early form of paper. The classical Greek historian Herodotus (ca. 480 BC) reported that the inhabitants of Scythia would often inhale the vapors of hemp-seed smoke, both as ritual and for their own pleasurable recreation.